Effective monitoring of isotretinoin safety in a pediatric dermatology population: A novel patient symptom survey approach

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

卷:65

Article

Hodgkiss-Harlow, Chelsea J.²  Eichenfield, Lawrence E.^1,2  Dohil, Magdalene A.^1,2 

[1] Rady Childrens Hosp, Div Pediat & Adolescent Dermatol, San Diego, CA 92123 USA

[2] Univ Calif San Diego, Sch Med, San Diego, CA 92123 USA

关键词: acne;    adolescent;    depression;    isotretinoin;    pediatrics;    symptom survey;   

DOI  :  10.1016/j.jaad.2010.06.040

来源: Elsevier

【 摘 要 】

Background. Assessment of adverse effects in pediatric patients on oral isotretinoin has not been standardized and the exact incidence is unknown. Objective: Our goal was to determine the usefulness of an isotretinoin symptom survey as a screening tool for assessment and quantification of adverse effects, including psychiatric symptoms, during isotretinoin treatment in a pediatric population of different age groups. Methods: We performed a retrospective chart review on a random sample of patients treated with isotretinoin at a tertiary pediatric dermatology clinic where patients completed an isotretinoin symptom survey at each visit. Responses were stratified by age group and psychiatric history. Results: The charts of 102 patients, representing 123 courses of isotretinoin and 760 treatment-months, were reviewed. A total of 722 (95.0%) symptom surveys were complete and 38 (5.0%) were incomplete/missing. Recorded side effects were similar to published adult data; dry lips/dry skin were reported in 94.25% and 72.13% of treatment-months of isotretinoin, respectively. Psychiatric symptoms were reported in 1.65%, with no statistical difference between patients with or without a mental health history. Patients aged 11 to 15 years had similar side-effect profiles to those aged 16 to 21 years. Impaired night vision, nosebleeds, and dry/bloodshot eyes were more common in the older age group. Limitations: This was a retrospective chart review, with known limitations. The study was performed at a tertiary referral center for pediatric dermatology, possibly allowing patient selection bias. Conclusions: The isotretinoin symptom survey appears to be an effective screening tool to standardize monitoring of isotretinoin side effects in the pediatric population. (J Am Acad Dermatol 2011;65:517-24.)

【 授权许可】

Free